Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management

3: MDT collaboration in NSCLC - Aligning oncologists, nurses, and patients to enhance EGFR inhibitor treatment pathways and supportive care

ASCO 2026: Highlights and analysis

Bupropion shows benefit for cancer-related fatigue in cancer survivors

Tarlatamab in SCLC shows consistent effect and low immune toxicity across age groups

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Sevabertinib shows manageable diarrhoea without impacting efficacy in HER2-mutant lung cancer

EAU 2026: Updates in NMIBC